3,748 results on '"Ettl A"'
Search Results
2. Second Victim: Übersetzung der internationalen konsensbasierten Definition mittels Delphi-Methode
Catalog
Books, media, physical & digital resources
3. ABC7-Konsens zur Systemtherapie des fortgeschrittenen Mammakarzinoms
4. PresAIse, A Prescriptive AI Solution for Enterprises
5. Long-term prospective outcome data using EndoPredict as risk stratification and chemotherapy decision biomarker in hormone receptor-positive, HER2-negative early breast cancer
6. In search of innovative potential: The challenge of measuring disruptiveness of research using bibliometric data
7. Endokrine Therapie des Mammakarzinoms beim Mann
8. The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype
9. Predictors for prolonged and escalated perioperative antibiotic therapy after microvascular head and neck reconstruction: a comprehensive analysis of 446 cases
10. Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer
11. The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype
12. Predictors for prolonged and escalated perioperative antibiotic therapy after microvascular head and neck reconstruction: a comprehensive analysis of 446 cases
13. Revisions of Evidence-Based Governance: The Case of the Austrian Quality Management System SQA
14. Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study.
15. Technik + Diversität = Vorbild im Wissenschaftskontext?
16. Die (un-)sichtbare Gestalterin sozialer Innovationen
17. Kind, Karriere – kein Problem?
18. Unverzichtbar und dennoch unsichtbar im Unternehmen?
19. Mehrfachgründung im Spagat zwischen Kultur und Innovation
20. Werte und Wandel in Familienunternehmen
21. Einleitung
22. Zwischen Pseudoprogression und Tumorregression: Immuncheckpointinhibitoren im Einsatz
23. Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer
24. Loss-Leader Pricing Strategies for Personalized Bundles under Customer Choice.
25. Unterstützung Wirksamer Führung Durch Personaldiagnostisch Gestütztes (business-)Coaching
26. The Integration of Refugees in Small and Medium-Sized Enterprises (SMEs): Case Studies from Practice
27. Organisationskultur – Aufbau, Modelle und aktuelle Entwicklungen
28. The Effects of Formal and Informal Institutions on Women’s Entrepreneurship in Georgia
29. Treatment of late-onset temporomandibular joint prosthesis infection by prosthesis revision: a case report
30. Gynäkologische Onkologie: Immunantwort aktivieren
31. Kollegiale Hilfe (KoHi) – Beschreibung des Interventionsprogramms zur Reduktion der Auswirkung belastender Arbeitssituationen im Sinne des Second-Victim-Phänomens bei patientennah tätigem Personal in der Klinik Hietzing, Wien, Österreich (KoHi-II-Studie)
32. Constrained Prescriptive Trees via Column Generation
33. Bringing Civil War Soldiers to Life
34. PROTECT – PUSH – PISS! A novel mnemonic for the treatment of hyperkalemia
35. The immunomodulatory ballet of tumour‐derived extracellular vesicles and neutrophils orchestrating the dynamic CD73/PD‐L1 pathway in cancer
36. 'Utility of Smartphone-based Three-dimensional Surface Imaging for Digital Facial Anthropometry'
37. Subcellular localization of PD‐L1 and cell‐cycle‐dependent expression of nuclear PD‐L1 variants: implications for head and neck cancer cell functions and therapeutic efficacy
38. Kraniomandibuläre Dysfunktionen bei Senioren
39. Publisher Erratum zu: Innovatorinnen gestalten Zukunft
40. Schluss
41. Benchmarking medical laboratory performance on a global scale
42. Antiresorptive agents enhance ossification of free flap reconstructions of the mandible: a radiological retrospective cohort study
43. Immune modulation in transplant medicine: a comprehensive review of cell therapy applications and future directions
44. Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study
45. Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline BRCA1/2-Mutated Breast CancerTalazoparib in Germline BRCA1/2-Mutated Breast Cancer
46. Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study
47. Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study
48. Quantum technology 2.0 -- topics and contributing countries from 1980 to 2018
49. Incidence and Survival of Out-of-Hospital Cardiac Arrest in Public Housing Areas in 3 European Capitals
50. PresAIse, A Prescriptive AI Solution for Enterprises.
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.